AcceleRET-Lung
Phase 3 Terminated
223 enrolled 18 charts
Pembro+Chemo in Brain Mets
Phase 2 Terminated
3 enrolled 7 charts
KEYVIBE-001
Phase 1 Completed
474 enrolled 39 charts
Carboplatin and Bevacizumab for Recurrent Ependymoma
Phase 2 Completed
35 enrolled 17 charts
EURTAC
Phase 3 Completed
174 enrolled 20 charts
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
Phase 1 Completed
829 enrolled 100 charts
AVANA
Phase 3 Completed
731 enrolled 19 charts
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Phase 2/3 Completed
361 enrolled 16 charts
Safety, PK and Efficacy of NOX66 as a Monotherapy and Combined With Carboplatin in Refractory Solid Tumours
Phase 1/2 Completed
19 enrolled 12 charts
DENALI
Phase 2 Completed
82 enrolled 10 charts
CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)
Phase 1 Completed
16 enrolled 14 charts
A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors
Phase 1 Completed
8 enrolled 26 charts
MK-2206-003
Phase 1 Completed
77 enrolled 24 charts
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling
Phase 1 Completed
65 enrolled 32 charts
A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma
Phase 2 Completed
90 enrolled 13 charts
Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma
Phase 2 Terminated
81 enrolled 15 charts
GSK1120212 Rollover Study
Phase 2 Terminated
159 enrolled 9 charts
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
Phase 1/2 Terminated
15 enrolled 11 charts
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before
Phase 2 Completed
64 enrolled 20 charts
Dose-finding Study in Platinum-Resistant Ovarian Cancer
Phase 1/2 Completed
59 enrolled 18 charts
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
Phase 1 Completed
9 enrolled 7 charts
Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors
Phase 1 Completed
34 enrolled 18 charts
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase 2 Completed
103 enrolled 13 charts
Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
Phase 1/2 Terminated
57 enrolled 11 charts
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Phase 1 Completed
43 enrolled 21 charts
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)
Phase 2 Completed
62 enrolled 9 charts
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours
Phase 1 Completed
83 enrolled 42 charts
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
Phase 2 Completed
51 enrolled 7 charts
Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL
Phase 2 Completed
20 enrolled 6 charts
FALCON
Phase 2 Completed
63 enrolled 18 charts
RAD001 Plus Carboplatin in Breast Cancer Patients
Phase 2 Completed
25 enrolled 9 charts
Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer
Phase 2 Completed
60 enrolled 10 charts
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
63 enrolled 15 charts
RAD0201
Phase 1/2 Completed
30 enrolled 8 charts
ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer
Phase 2 Terminated
120 enrolled 8 charts
Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor
Phase 1 Completed
102 enrolled 48 charts
Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors
Phase 2 Completed
12 enrolled 6 charts